Selected research
Market Analysis & Forecast
Global Anti-Infectives Market Analysis and Forecast 2026-2032
Market perspective
The global Anti-Infectives market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Anti-Infectives is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Anti-Infectives is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Anti-Infectives is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Anti-Infectives is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Anti-Infectives include Astra Zeneca plc, Glaxo SmithKline plc, Novartis, Wockhardt ltd, Pfizer, Roche, Merck, Johnson & Johnson and Sanofi, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Anti-Infectives, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Anti-Infectives, also provides the sales of main regions and countries. Of the upcoming market potential for Anti-Infectives, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Anti-Infectives sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Anti-Infectives market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Anti-Infectives sales, projected growth trends, production technology, application and end-user industry.
Anti-Infectives Segment by Company
Astra Zeneca plc
Glaxo SmithKline plc
Novartis
Wockhardt ltd
Pfizer
Roche
Merck
Johnson & Johnson
Sanofi
Anti-Infectives Segment by Type
Antifungal
Antibacterial
Antiviral
Anti-Infectives Segment by Application
Retail Pharmacies
Mail Order Pharmacies
Hospital Pharmacies
Anti-Infectives Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-Infectives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anti-Infectives and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-Infectives.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Anti-Infectives in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Anti-Infectives manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anti-Infectives sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Antifungal
- Antibacterial
- Antiviral
Applications
- Retail Pharmacies
- Mail Order Pharmacies
- Hospital Pharmacies
Companies covered
- Astra Zeneca plc
- Glaxo SmithKline plc
- Novartis
- Wockhardt ltd
- Pfizer
- Roche
- Merck
- Johnson & Johnson
- Sanofi
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Anti-Infectives Market by Type
- 1.2.1 Global Anti-Infectives Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Antifungal
- 1.2.3 Antibacterial
- 1.2.4 Antiviral
- 1.3 Anti-Infectives Market by Application
- 1.3.1 Global Anti-Infectives Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Retail Pharmacies
- 1.3.3 Mail Order Pharmacies
- 1.3.4 Hospital Pharmacies
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Anti-Infectives Market Dynamics
- 2.1 Anti-Infectives Industry Trends
- 2.2 Anti-Infectives Industry Drivers
- 2.3 Anti-Infectives Industry Opportunities and Challenges
- 2.4 Anti-Infectives Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Anti-Infectives Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Anti-Infectives Revenue by Region
- 3.2.1 Global Anti-Infectives Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Anti-Infectives Revenue by Region (2021-2026)
- 3.2.3 Global Anti-Infectives Revenue by Region (2027-2032)
- 3.2.4 Global Anti-Infectives Revenue Market Share by Region (2021-2032)
- 3.3 Global Anti-Infectives Sales Estimates and Forecasts 2021-2032
- 3.4 Global Anti-Infectives Sales by Region
- 3.4.1 Global Anti-Infectives Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Anti-Infectives Sales by Region (2021-2026)
- 3.4.3 Global Anti-Infectives Sales by Region (2027-2032)
- 3.4.4 Global Anti-Infectives Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Anti-Infectives Revenue by Manufacturers
- 4.1.1 Global Anti-Infectives Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Anti-Infectives Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Anti-Infectives Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Anti-Infectives Sales by Manufacturers
- 4.2.1 Global Anti-Infectives Sales by Manufacturers (2021-2026)
- 4.2.2 Global Anti-Infectives Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Anti-Infectives Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Anti-Infectives Sales Price by Manufacturers (2021-2026)
- 4.4 Global Anti-Infectives Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Anti-Infectives Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Anti-Infectives Manufacturers, Product Type & Application
- 4.7 Global Anti-Infectives Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Anti-Infectives Market CR5 and HHI
- 4.8.2 2025 Anti-Infectives Tier 1, Tier 2, and Tier 3
5 Anti-Infectives Market by Type
- 5.1 Global Anti-Infectives Revenue by Type
- 5.1.1 Global Anti-Infectives Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Anti-Infectives Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Anti-Infectives Revenue Market Share by Type (2021-2032)
- 5.2 Global Anti-Infectives Sales by Type
- 5.2.1 Global Anti-Infectives Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Anti-Infectives Sales by Type (2021-2032) & (W Units)
- 5.2.3 Global Anti-Infectives Sales Market Share by Type (2021-2032)
- 5.3 Global Anti-Infectives Price by Type
6 Anti-Infectives Market by Application
- 6.1 Global Anti-Infectives Revenue by Application
- 6.1.1 Global Anti-Infectives Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Anti-Infectives Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Anti-Infectives Revenue Market Share by Application (2021-2032)
- 6.2 Global Anti-Infectives Sales by Application
- 6.2.1 Global Anti-Infectives Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Anti-Infectives Sales by Application (2021-2032) & (W Units)
- 6.2.3 Global Anti-Infectives Sales Market Share by Application (2021-2032)
- 6.3 Global Anti-Infectives Price by Application
7 Company Profiles
- 7.1 Astra Zeneca plc
- 7.1.1 Astra Zeneca plc Company Information
- 7.1.2 Astra Zeneca plc Business Overview
- 7.1.3 Astra Zeneca plc Anti-Infectives Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Astra Zeneca plc Anti-Infectives Product Portfolio
- 7.1.5 Astra Zeneca plc Recent Developments
- 7.2 Glaxo SmithKline plc
- 7.2.1 Glaxo SmithKline plc Company Information
- 7.2.2 Glaxo SmithKline plc Business Overview
- 7.2.3 Glaxo SmithKline plc Anti-Infectives Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Glaxo SmithKline plc Anti-Infectives Product Portfolio
- 7.2.5 Glaxo SmithKline plc Recent Developments
- 7.3 Novartis
- 7.3.1 Novartis Company Information
- 7.3.2 Novartis Business Overview
- 7.3.3 Novartis Anti-Infectives Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Novartis Anti-Infectives Product Portfolio
- 7.3.5 Novartis Recent Developments
- 7.4 Wockhardt ltd
- 7.4.1 Wockhardt ltd Company Information
- 7.4.2 Wockhardt ltd Business Overview
- 7.4.3 Wockhardt ltd Anti-Infectives Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Wockhardt ltd Anti-Infectives Product Portfolio
- 7.4.5 Wockhardt ltd Recent Developments
- 7.5 Pfizer
- 7.5.1 Pfizer Company Information
- 7.5.2 Pfizer Business Overview
- 7.5.3 Pfizer Anti-Infectives Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Pfizer Anti-Infectives Product Portfolio
- 7.5.5 Pfizer Recent Developments
- 7.6 Roche
- 7.6.1 Roche Company Information
- 7.6.2 Roche Business Overview
- 7.6.3 Roche Anti-Infectives Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Roche Anti-Infectives Product Portfolio
- 7.6.5 Roche Recent Developments
- 7.7 Merck
- 7.7.1 Merck Company Information
- 7.7.2 Merck Business Overview
- 7.7.3 Merck Anti-Infectives Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Merck Anti-Infectives Product Portfolio
- 7.7.5 Merck Recent Developments
- 7.8 Johnson & Johnson
- 7.8.1 Johnson & Johnson Company Information
- 7.8.2 Johnson & Johnson Business Overview
- 7.8.3 Johnson & Johnson Anti-Infectives Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Johnson & Johnson Anti-Infectives Product Portfolio
- 7.8.5 Johnson & Johnson Recent Developments
- 7.9 Sanofi
- 7.9.1 Sanofi Company Information
- 7.9.2 Sanofi Business Overview
- 7.9.3 Sanofi Anti-Infectives Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 Sanofi Anti-Infectives Product Portfolio
- 7.9.5 Sanofi Recent Developments
8 North America
- 8.1 North America Anti-Infectives Market Size by Type
- 8.1.1 North America Anti-Infectives Revenue by Type (2021-2032)
- 8.1.2 North America Anti-Infectives Sales by Type (2021-2032)
- 8.1.3 North America Anti-Infectives Price by Type (2021-2032)
- 8.2 North America Anti-Infectives Market Size by Application
- 8.2.1 North America Anti-Infectives Revenue by Application (2021-2032)
- 8.2.2 North America Anti-Infectives Sales by Application (2021-2032)
- 8.2.3 North America Anti-Infectives Price by Application (2021-2032)
- 8.3 North America Anti-Infectives Market Size by Country
- 8.3.1 North America Anti-Infectives Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Anti-Infectives Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Anti-Infectives Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Anti-Infectives Market Size by Type
- 9.1.1 Europe Anti-Infectives Revenue by Type (2021-2032)
- 9.1.2 Europe Anti-Infectives Sales by Type (2021-2032)
- 9.1.3 Europe Anti-Infectives Price by Type (2021-2032)
- 9.2 Europe Anti-Infectives Market Size by Application
- 9.2.1 Europe Anti-Infectives Revenue by Application (2021-2032)
- 9.2.2 Europe Anti-Infectives Sales by Application (2021-2032)
- 9.2.3 Europe Anti-Infectives Price by Application (2021-2032)
- 9.3 Europe Anti-Infectives Market Size by Country
- 9.3.1 Europe Anti-Infectives Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Anti-Infectives Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Anti-Infectives Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Anti-Infectives Market Size by Type
- 10.1.1 China Anti-Infectives Revenue by Type (2021-2032)
- 10.1.2 China Anti-Infectives Sales by Type (2021-2032)
- 10.1.3 China Anti-Infectives Price by Type (2021-2032)
- 10.2 China Anti-Infectives Market Size by Application
- 10.2.1 China Anti-Infectives Revenue by Application (2021-2032)
- 10.2.2 China Anti-Infectives Sales by Application (2021-2032)
- 10.2.3 China Anti-Infectives Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Anti-Infectives Market Size by Type
- 11.1.1 Asia Anti-Infectives Revenue by Type (2021-2032)
- 11.1.2 Asia Anti-Infectives Sales by Type (2021-2032)
- 11.1.3 Asia Anti-Infectives Price by Type (2021-2032)
- 11.2 Asia Anti-Infectives Market Size by Application
- 11.2.1 Asia Anti-Infectives Revenue by Application (2021-2032)
- 11.2.2 Asia Anti-Infectives Sales by Application (2021-2032)
- 11.2.3 Asia Anti-Infectives Price by Application (2021-2032)
- 11.3 Asia Anti-Infectives Market Size by Country
- 11.3.1 Asia Anti-Infectives Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Anti-Infectives Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Anti-Infectives Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Anti-Infectives Market Size by Type
- 12.1.1 SAMEA Anti-Infectives Revenue by Type (2021-2032)
- 12.1.2 SAMEA Anti-Infectives Sales by Type (2021-2032)
- 12.1.3 SAMEA Anti-Infectives Price by Type (2021-2032)
- 12.2 SAMEA Anti-Infectives Market Size by Application
- 12.2.1 SAMEA Anti-Infectives Revenue by Application (2021-2032)
- 12.2.2 SAMEA Anti-Infectives Sales by Application (2021-2032)
- 12.2.3 SAMEA Anti-Infectives Price by Application (2021-2032)
- 12.3 SAMEA Anti-Infectives Market Size by Country
- 12.3.1 SAMEA Anti-Infectives Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Anti-Infectives Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Anti-Infectives Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Anti-Infectives Value Chain Analysis
- 13.1.1 Anti-Infectives Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Anti-Infectives Production Mode & Process
- 13.2 Anti-Infectives Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Anti-Infectives Distributors
- 13.2.3 Anti-Infectives Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst